Table 2.
Mean heart rate pre-ablation and during follow-up
| Group | HR response | Pre-ablation | 3 months | P-value | 6 months | P-value | 12 months | P-value |
|---|---|---|---|---|---|---|---|---|
| Overall | 63.5 ± 8.4 | 69.1 ± 9.9 | < 0.001 | 71.9 ± 9.4 | < 0.001 | 71.2 ± 10.1 | < 0.001 | |
| Group 1a | 63.5 ± 8.3 | 68.4 ± 9.3 | < 0.001 | 71.6 ± 9.4 | < 0.001 | 71.0 ± 10.1 | < 0.001 | |
| Group 2b | Abnormal sinus HR response | 61.9 ± 10.6 | 84.6 ± 9.8 | < 0.001 | 80.1 ± 6.5 | 0.007 | 76.3 ± 10.1 | 0.033 |
| HR increase ≥ 20 bpm | 59.8 ± 10.0 | 83.2 ± 9.9 | < 0.001 | 78.5 ± 5.2 | 0.017 | 75.5 ± 10.8 | 0.049 | |
| IST | 73.0 ± 1.0 | 94.0 ± 1.0 | 0.002 | 80.0 ± 8.7 | 0.261 | 76.7 ± 10.2 | 0.604 |
Data are mean heart rate ± standard deviation) in beats per minute. P-values are based on difference at follow-up compared with pre-ablation
a Group 1 comprises patients with normal heart rate (HR) response
b Group 2 comprises patients with abnormal sinus HR response (HR increase ≥ 20 bpm and/or inappropriate sinus tachycardia (IST))